Ghent University Academic Bibliography

Show Sort by

Your filters: cql: affiliation exact FW cql: author exact 001994348086

Add to list
- Journal Article
- open access
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer?s Disease Mouse Model

Philipp Spatz, Sophie A. M. Steinmueller, Anna Tutov, Eleonora Poeta, Axelle Morilleau, Allison Carles, Marie Deventer (UGent) , Julian Hofmann, Christophe Stove (UGent) , Barbara Monti, et al.

(2023) JOURNAL OF MEDICINAL CHEMISTRY. 66(9). p.6414-6435
Add to list
- Journal Article
- open access
Application of a Fully Automated Dried Blood Spot Method for Therapeutic Drug Monitoring of Immunosuppressants

Sigrid Deprez (UGent) and Christophe Stove (UGent)

(2023) ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 147(7). p.786-796
Add to list
- Journal Article
Off-target activity of NBOMes and NBOMe analogs at the mu opioid receptor

Marie Deventer (UGent) , Mattias Persson, Antonio Laus, Eline Pottie (UGent) , Annelies Cannaert (UGent) , Graziella Tocco, Henrik Green and Christophe Stove (UGent)

(2023) ARCHIVES OF TOXICOLOGY. 97(5). p.1367-1384
Add to list
- Journal Article
- A1
- open access
The P2Y(2) receptor C-terminal tail modulates but is dispensable for beta-arrestin recruitment

Eline Pottie (UGent) , Jolien Storme and Christophe Stove (UGent)

(2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(7).
Add to list
- Journal Article
- A1
- open access
In-depth evaluation of automated non-contact reflectance-based hematocrit prediction of dried blood spots

Laura Boffel (UGent) , Liesl Heughebaert (UGent) , Stijn Lambrecht (UGent) , Marc Luginbuehl and Christophe Stove (UGent)

(2022) ANALYST. 147(23). p.5445-5454
Add to list
- Journal Article
- A1
- open access
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs

Bram Bogaert (UGent) , Felix Sauvage, Roberta Guagliardo, Cristina Muntean (UGent) , [missing] Van Phuc Nguyen, Eline Pottie (UGent) , Mike Wels (UGent) , An-Katrien Minnaert (UGent) , Riet De Rycke (UGent) , Qiangbing Yang, et al.

(2022) JOURNAL OF CONTROLLED RELEASE. 350. p.256-270
Add to list
- Journal Article
- A1
- open access
First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Marthe Vandeputte (UGent) , Nick Verougstraete (UGent) , Donna Walther, Grant C. Glatfelter, Jeroen Malfliet, Michael H. Baumann, Alain Verstraete (UGent) and Christophe Stove (UGent)

(2022) ARCHIVES OF TOXICOLOGY. 96(6). p.1865-1880
Add to list
Development of an indole-amide-based photoswitchable cannabinoid receptor subtype 1 (CB1R) 'Cis-On' Agonist

Diego A. Rodríguez-Soacha, Sophie A. M. Steinmüller, Ali Işbilir, Julia Fender, Marie Deventer (UGent) , Yesid A. Ramírez, Anna Tutov, Christoph Sotriffer, Christophe Stove (UGent) , Kristina Lorenz, et al.

(2022) ACS CHEMICAL NEUROSCIENCE. 13(16). p.2410-2435
Add to list
- Journal Article
- A1
- open access
In vitro functional assays as a tool to study new synthetic opioids at the mu-opioid receptor : potential, pitfalls and progress

Marthe Vandeputte (UGent) , Lakshmi Vasudevan and Christophe Stove (UGent)

(2022) PHARMACOLOGY & THERAPEUTICS. 235.
Add to list
- Journal Article
- A1
- open access
Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid

Marthe Vandeputte (UGent) , Alex J. Krotulski, Donna Walther, Grant C. Glatfelter, Donna Papsun, Sara E. Walton, Barry K. Logan, Michael H. Baumann and Christophe Stove (UGent)

(2022) ARCHIVES OF TOXICOLOGY. 96(6). p.1845-1863

Academic Bibliography

Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer?s Disease Mouse Model

Application of a Fully Automated Dried Blood Spot Method for Therapeutic Drug Monitoring of Immunosuppressants

Off-target activity of NBOMes and NBOMe analogs at the mu opioid receptor

The P2Y(2) receptor C-terminal tail modulates but is dispensable for beta-arrestin recruitment

In-depth evaluation of automated non-contact reflectance-based hematocrit prediction of dried blood spots

A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Development of an indole-amide-based photoswitchable cannabinoid receptor subtype 1 (CB1R) 'Cis-On' Agonist

In vitro functional assays as a tool to study new synthetic opioids at the mu-opioid receptor : potential, pitfalls and progress

Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid

Contents

Support

Contact